Modulation of Fibrosis in Systemic Sclerosis by Nitric Oxide and Antioxidants

Por Dooley, Audrey, Bruckdorfer, K. Richard, Abraham, David J.
Publicado em 2012

Sixth International Workshop on Scleroderma Research, Oxford, UK, 30 July–2 August 2000

Por Wollheim, Frank A, Denton, Christopher P, Abraham, David J
Publicado em 2001

Cell Signalling Pathways Leading to Novel Therapeutic Strategies in Cardiovascular Disease

Por Shaw, Sidney G., Abraham, David J., Baker, Daryll M., Tsui, Janice
Publicado em 2012

Pericytes display increased CCN2 expression upon culturing

Por Shiwen, Xu, Rajkumar, Vineeth, Denton, Christopher P., Leask, Andrew, Abraham, David J.
Publicado em 2009

STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiatio...

Por Papaioannou, Ioannis, Xu, Shiwen, Denton, Christopher P., Abraham, David J., Ponticos, Markella
Publicado no Mol Biol Cell (2018)

Regulation of Collagen Type I in Vascular Smooth Muscle Cells by Competition between Nkx2.5 and δEF1/ZEB1

Por Ponticos, Markella, Partridge, Terrence, Black, Carol M., Abraham, David J., Bou-Gharios, George
Publicado em 2004

Agonistic anti-ICAM-1 antibodies in scleroderma: Activation of endothelial pro-inflammatory cascades

Por Wolf, Sabine I., Howat, Sarah, Abraham, David J., Pearson, Jeremy D., Lawson, Charlotte
Publicado em 2013

Elevated CCN2 expression in scleroderma: a putative role for the TGFβ accessory receptors TGFβRIII and endoglin

Por Holmes, Alan M., Ponticos, Markella, Shi-wen, Xu, Denton, Christopher P., Abraham, David J.
Publicado em 2011

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

Por Rajkumar, Vineeth S, Howell, Kevin, Csiszar, Katalin, Denton, Christopher P, Black, Carol M, Abraham, David J
Publicado em 2005

Potential of Novel EPO Derivatives in Limb Ischemia

Por Joshi, Dhiraj, Tsui, Janice, Yu, Rebekah, Shiwen, Xu, Selvakumar, Sadasivam, Abraham, David J., Baker, Daryll M.
Publicado em 2012

Rac Inhibition Reverses the Phenotype of Fibrotic Fibroblasts

Por Shi-wen, Xu, Liu, Shangxi, Eastwood, Mark, Sonnylal, Sonali, Denton, Christopher P., Abraham, David J., Leask, Andrew
Publicado em 2009

CCN2 (Connective Tissue Growth Factor) Promotes Fibroblast Adhesion to Fibronectin

Por Chen, Yunliang, Abraham, David J., Shi-wen, Xu, Pearson, Jeremy D., Black, Carol M., Lyons, Karen M., Leask, Andrew
Publicado em 2004

Lymphatic and blood vessels in scleroderma skin, a morphometric analysis

Por Rossi, Antonella, Sozio, Francesca, Sestini, Piersante, Renzoni, Elisabetta A., Khan, Korsa, Denton, Christopher P., Abraham, David J., Weber, Elisabetta
Publicado em 2010

Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity

Por Taher, Taher E., Bystrom, Jonas, Ong, Voon H., Isenberg, David A., Renaudineau, Yves, Abraham, David J., Mageed, Rizgar A.
Publicado no Clin Rev Allergy Immunol (2017)

Morphometric analysis of intralobular, interlobular and pleural lymphatics in normal human lung

Por Sozio, Francesca, Rossi, Antonella, Weber, Elisabetta, Abraham, David J, Nicholson, Andrew G, Wells, Athol U, Renzoni, Elisabetta A, Sestini, Piersante
Publicado em 2012

Failed Degradation of JunB Contributes to Overproduction of Type I Collagen and Development of Dermal Fibrosis in Patients With Systemic Sclerosis

Por Ponticos, Markella, Papaioannou, Ioannis, Xu, Shiwen, Holmes, Alan M, Khan, Korsa, Denton, Christopher P, Bou-Gharios, George, Abraham, David J
Publicado no Arthritis Rheumatol (2015)

Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellul...

Por Chen, Yunliang, Leask, Andrew, Abraham, David J, Kennedy, Laura, Shi-wen, Xu, Denton, Christopher P, Black, Carol M, Verjee, Liaquat S, Eastwood, Mark
Publicado em 2011

Erratum to: Thrombospondin 1 is a key mediator of transforming growth factor b-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)...

Por Chen, Yunliang, Leask, Andrew, Abraham, David J, Kennedy, Laura, Shi-wen, Xu, Denton, Christopher P, Black, Carol M, Verjee, Liaquat S, Eastwood, Mark
Publicado no Fibrogenesis Tissue Repair (2015)

Molecular Basis for Dysregulated Activation of NKX2‐5 in the Vascular Remodeling of Systemic Sclerosis

Por Dritsoula, Athina, Papaioannou, Ioannis, Guerra, Sandra G., Fonseca, Carmen, Martin, Javier, Herrick, Ariane L., Abraham, David J., Denton, Christopher P., Ponticos, Markella
Publicado no Arthritis Rheumatol (2018)

GSK-3β in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1–dependent mechanism

Por Kapoor, Mohit, Liu, Shangxi, Shi-wen, Xu, Huh, Kun, McCann, Matthew, Denton, Christopher P., Woodgett, James R., Abraham, David J., Leask, Andrew
Publicado em 2008